Los Angeles Capital Management LLC Increases Holdings in GE HealthCare Technologies Inc. $GEHC

Los Angeles Capital Management LLC raised its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 146.6% in the 4th quarter, HoldingsChannel reports. The fund owned 23,372 shares of the company’s stock after buying an additional 13,895 shares during the quarter. Los Angeles Capital Management LLC’s holdings in GE HealthCare Technologies were worth $1,753,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Laurel Wealth Advisors LLC purchased a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $26,000. Optima Capital LLC purchased a new position in GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Godfrey Financial Associates Inc. purchased a new position in GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Montag A & Associates Inc. raised its holdings in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 175 shares in the last quarter. Finally, Maseco LLP acquired a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $29,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Insider Buying and Selling at GE HealthCare Technologies

In related news, Director Kevin Lobo purchased 10,000 shares of the stock in a transaction that occurred on Friday, May 22nd. The shares were purchased at an average price of $64.18 per share, with a total value of $641,800.00. Following the completion of the acquisition, the director directly owned 14,363 shares in the company, valued at $921,817.34. This represents a 229.20% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Peter J. Arduini purchased 4,169 shares of the company’s stock in a transaction that occurred on Thursday, April 30th. The stock was bought at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the transaction, the chief executive officer directly owned 259,424 shares in the company, valued at $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders have acquired 21,847 shares of company stock valued at $1,361,355. Corporate insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $63.76 on Thursday. The firm’s fifty day simple moving average is $66.59 and its 200-day simple moving average is $75.36. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The stock has a market capitalization of $29.00 billion, a price-to-earnings ratio of 15.25, a PEG ratio of 1.49 and a beta of 0.74. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. During the same quarter in the prior year, the company earned $1.01 EPS. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on GEHC. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lowered their target price for the company from $75.00 to $69.00 in a report on Thursday, May 21st. BNP Paribas Exane reduced their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st. Weiss Ratings downgraded shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 15th. Stifel Nicolaus set a $80.00 price objective on GE HealthCare Technologies in a report on Wednesday, April 29th. Finally, Argus cut their target price on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Tuesday, May 19th. Nine investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $80.21.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.